Immature dendritic cells (imDCs) can have a tolerizing effect under normal conditions or after transplantation. However, because of the significant heterogeneity of this cell population, it is extremely difficult to study the mechanisms that mediate the tolerance induced or to harness the application of imDCs for clinical use. In the present study, we describe the generation of a highly defined population of imDCs from hematopoietic progenitors and the direct visualization of the fate of TCR-transgenic alloreactive CD4 ؉ and CD8 ؉ T cells after encountering cognate or noncognate imDCs. Whereas CD4 ؉ T cells were deleted via an MHC-independent mechanism through the NO system, CD8 ؉ T-cell deletion was found to occur through a unique MHCdependent, perforin-based killing mechanism involving activation of TLR7 and signaling through Triggering Receptor-1 Expressed on Myeloid cells (TREM-1). This novel subpopulation of perforinexpressing imDCs was also detected in various lymphoid tissues in normal animals and its frequency was markedly enhanced after GM-CSF administration.
IntroductionCentral and peripheral tolerance mechanisms are critical for the establishment of a robust immune response that can distinguish between self-and nonself-antigens. Although the majority of self-specific T cells are deleted by negative selection in the thymus, some self-reactive T cells are spared and can reach peripheral organs. 1,2 A wealth of evidence indicates that dendritic cells (DCs) have tolerogenic capacity in their immature state (imDCs). [3][4][5][6][7][8] In the context of allogeneic organ transplantation, infusion of imDCs expressing the relevant MHC-peptide complex can prolong allograft survival in vivo. 7,[9][10][11][12] At the same time, imDCs can become immunogenic on maturation/activation in the presence of a danger signal such as lipopolysaccharide (LPS). However, this simplistic paradigm was recently challenged by the demonstration that fully mature DCs can also induce tolerance under the appropriate conditions, [13][14][15][16][17] suggesting a more complex decision-making process in which the net effect of Ag dose, DC lineage, DC maturation and activation state, and the cytokine milieu at the site of inflammation determine whether immunogenic or tolerogenic DC activity will prevail. 18 The tolerogenic potential of immature or mature DCs can be further extended to the resolution of inflammatory responses to pathogens. 19 Lymphoid organs, including spleen, bone marrow (BM), lymph nodes, and thymus, contain multiple DC subpopulations largely defined by their distinct anatomical location and phenotypes. 20,21 For example, the mouse spleen harbors plasmacytoid DCs (pDCs) and the CD8 ϩ and CD8 Ϫ subsets of classic DCs (cDCs). 20 Apart from the major steady-state dichotomy of differentiation into pDCs versus cDCs, an additional distinct monocyte-derived DC subset with phenotypic characteristics of cDCs is recruited to sites of inflammation. 22 The phenotypic heterogeneity of DCs and growing data on their distinct origins p...